# Neuros Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuros-medical

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.neurosmedical.com
- Total disclosed funding: $139M
- Latest round: Series D (Jul 9, 2025)
- Investors on record: 20

## About

Founded in 2008 and based in California, US, Neuros Medical, Inc. operates as a medical device company. The company was founded by Kevin Kilgore and Niloy Bhadra. In October 2023, Neuros Medical, Inc. raised USD 25 million in growth funding from Trinity Capital Investment. As of 2023, the company’s CEO and President is Thomas Wilder.

Neuros Medical offers the Altius high-frequency nerve block system, a bioelectric on-demand nerve block technology that consists of an implantable generator, a cuff electrode, and external devices that are used for the treatment of chronic post-amputation phantom limb and residual limb pain. The firm also provides QUEST, a high-frequency nerve block for post-amputation pain study, which is a clinical trial run under an IDE (investigational device exemption) and is used to evaluate the security and efficacy of the company's Altius system.

The company plans to use the October 2023 growth funding to ramp up its operations and boost its commercial launch.

## Funding rounds

- Series D, Jul 9, 2025, $56M — US Venture Partners, EQT Life Sciences, Aperture Venture Partners, OUP (Osage University Partners), Sectoral Asset Management, Amzak Capital Management
- Series B, Apr 3, 2023 — Argonautic Ventures
- Series B, Apr 3, 2022 — Argonautic Ventures
- Series B, Aug 10, 2021 — Argonautic Ventures
- Series B, Oct 27, 2020, $37M — Argonautic Ventures
- Series B, Oct 27, 2020, $37M — US Venture Partners, Aperture Venture Partners, OUP (Osage University Partners), InCube Ventures, Sectoral Asset Management, Amzak Capital Management
- Series B, Apr 1, 2014, $4M — North Coast Ventures, BlueTree Allied Angels, Rev1 Ventures
- Series B, Jul 18, 2012, $3.5M — Northcoast Capital Management, RiverVest Ventures Partners, Jumpstart Solutions, Queen City Angels, Boston Scientific Ventures, Glengary, Case Technology Ventures, Blue Tree Allied Angels, Physician Investment Group, Rev1 Ventures
- Series A, Oct 23, 2009, $1.8M — Queen City Angels, Glengary, North Coast Ventures, Rev1 Ventures

## Investors

- Queen City Angels (https://capitalatlas.ai/funds/queen-city-angels) — Series A, Series B
- Glengary (https://capitalatlas.ai/funds/glengary) — Series A, Series B
- North Coast Ventures (https://capitalatlas.ai/funds/north-coast-ventures) — Series A, Series B
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series A, Series B
- Northcoast Capital Management (https://capitalatlas.ai/funds/northcoast-capital-management) — Series B
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series B
- Jumpstart Solutions (https://capitalatlas.ai/funds/jumpstart-solutions) — Series B
- Boston Scientific Ventures (https://capitalatlas.ai/funds/boston-scientific-ventures) — Series B
- Case Technology Ventures (https://capitalatlas.ai/funds/case-technology-ventures) — Series B
- Blue Tree Allied Angels — Series B
- Physician Investment Group — Series B
- BlueTree Allied Angels — Series B
- Argonautic Ventures (https://capitalatlas.ai/funds/argonautic-ventures) — Series B
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B, Series D
- Aperture Venture Partners (https://capitalatlas.ai/funds/aperture-venture-partners) — Series B, Series D
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B, Series D
- InCube Ventures — Series B
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series B, Series D
- Amzak Capital Management (https://capitalatlas.ai/funds/amzak-capital-management) — Series B, Series D
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series D